Skip to content

Fighting to Preserve the Benefits of the 340B Program

  • About Us
  • Contact Us
Top Bar Menu
Facebook page opens in new windowTwitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
RWC-340B
Ryan White Clinics for 340B Access
RWC-340B
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
    • Webinars
  • News
Search:
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
    • Webinars
  • News
RWC340B Logo Square 1000 × 1000 px

RWC-340B | 340B Statement of Principles

Read more
RWC340B Logo Square 1000 × 1000 px

RWC-340B Statement Regarding ASAP 340B Core Principles

Read more

Pharmaceutical Manufacturer 340B Price Restriction Policies and Exemptions Summary Chart Updated

Read more

North Texas HIV clinics face near $20M hit due to new PrEP reimbursement policy

Read more
340B Primer Cover

RWC-340B Webinar Replay: 340B Primer

Read more
RWC340B Logo Square 1000 × 1000 px

RWC-340B Releases Analysis Warning Federal and State Policymakers of Drug Industry Disinformation Campaign

Read more
RWC 340B Logo hi res 002

RWC-340B Submits Comments to HRSA regarding 340B Registration Changes

Read more
RWC 340B Logo hi res 002

RWC-340B Issues Press Statement Regarding PrEP Bill

Read more
Gilead

RWC-340B Decries Gilead Policies, Seeks Immediate Relief

Read more
FTC Logo

RWC-340B Submits Comments to Federal Trade Commission

Read more
Gilead

RWC-340B Sends Letters to Gilead, HHS Secretary, and OPA Director.

Read more
Johnson Johnson Logo

Johnson & Johnson is the 16th Manufacturer to Restrict Access to 340B Prices at Contract Pharmacies

Read more
Trent Smith Headshot 2022

Trent Smith hired as RWC-340B Managing Director

Read more
RWC 340B Logo hi res 002

RWC-340B Responds to Gilead’s Conditions on 340B Contract Pharmacy

Read more
Gilead

Gilead to Restrict Access to 340B Prices at Contract Pharmacies for Branded Hep-C Drugs; AbbVie Adds Imbruvica to Restrictive Contract Pharmacy Policy

Read more
Gilead

RWC-340B Sends Gilead Letter Requesting Exceptions for MAP/PAP Policies

Read more
bill 5665872 1920

Pfizer and GSK Announce Policies to Restrict Access to 340B Drugs at Contract Pharmacies; Novo Nordisk Modifies Its Policy

Read more
Joe Biden

POTUS Pledges to Enforce 340B Program

Read more
Hiring

RWC-340B Seeking Managing Director

Read more
Spanberger

Spanberger to HHS: Hold Drug Companies Accountable for Breaking the Law, Crack Down on Illegal Price Hikes

Read more
thought catalog kkysaOcVE94 unsplash

BMS is the 12th Manufacturer to Restrict Access to 340B Prices at Contract Pharmacies; Permits Designation of One Contract Pharmacy for Three Cancer Drugs

Read more
eye g4f3076735 1920

Second Sight Updates 340B ESP Terms of Use

Read more
volodymyr hryshchenko m1Hq4ibP9rc unsplash

New AbbVie and Lilly Contract Pharmacy Policies

Read more
glsun guilin WNX6uk 1LV4 unsplash

UCB Latest Manufacturer to Announce Restrictive Contract Pharmacy Policy; HRSA Issues Statement Regarding Manufacturer Lawsuits

Read more

Eighth Circuit Issues Favorable ERISA Preemption Decision that Likely Protects State 340B Anti-Discrimination Laws

Read more
courthouse g329b35186 1280

Update on 340B Contract Pharmacy Litigation — Decisions Issued in Four Manufacturer Lawsuits

Read more
RWC 340B Logo hi res

RWC-340B Applauds Court’s “Fairest and Most Reasonable” Interpretation of the 340B Drug Pricing Program: Manufacturer Actions Shall Not Undermine the Safety Net

Read more
index

Indiana Federal Court Issues Decision in Eli Lilly’s Contract Pharmacy Lawsuit

Read more
istockphoto 1285497344 612x612 1

Boehringer Ingelheim Is Latest Manufacturer to File a Lawsuit Against HHS On Contract Pharmacy Program

Read more
hammer ge8ffaccd3 1920

Rep. Matt Rosendale Introduces Legislation: DSH 340B Eligibility Moratorium, Regulations Limiting Such Eligibility, and Increased Reporting Requirements

Read more
tingey injury law firm nSpj Z12lX0 unsplash

Kalderos Sues HHS Over Contract Pharmacy Policy

Read more
waste paper gcbfb8becf 1920

United Therapeutics Seeks Records from HRSA Regarding Covered Entity Compliance with Duplicate Discount and Diversion Prohibitions

Read more
auction g4dc206f29 1920

Sanofi Files Emergency Motion to Halt ADR Proceedings

Read more
north ge08ff2fe4 1280

North Carolina PBM Reform Law Protects Certain 340B Covered Entity Types

Read more
pexels ekaterina bolovtsova 6077447

PhRMA Sues in Federal Court to Stop Enforcement of Arkansas Law

Read more
financial gf32557403 1920

Senator Braun (R-IN) Introduces Legislation to Authorize HHS to Audit 340B Income

Read more
letters g29b225827 1920

HRSA Refers Six Pharmaceutical Manufacturers to HHS-Office of the Inspector General for Imposition of Civil Monetary Penalties

Read more
pexels andrea piacquadio 3760067

Gilead Notifies Pharmacies of Its New PAP/MAP Policy

Read more
flag 28563 1280

Arkansas Law Suspended at PhRMA’s Request

Read more
joshua coleman AVqs0ItdMQM unsplash

Merck Restricts Purchases of 340B Drugs for 340B Hospitals Effective September 1

Read more
bill 5665872 1920

House Approves Spanberger-McKinley Amendment Supporting HRSA Action Against Drug Manufacturers

Read more
smartphone 6386599 1920

Coverage of PrEP and Other Preventative Services Without Cost-Sharing

Read more
savings 2789112 1920

House Appropriations Committee Issues Fiscal Year 2022 Appropriations Bill

Read more
news 2389226 640

The Parkersburg News and Sentinel – Protect 340B: Legislation needed for lowering drug pricing

Read more
support 2355701 1920

PROTECT 340B ACT Dear Colleague Letter

Read more
capital 5043172 640

Reps. McKinley and Spanberger Introduce Bi-Partisan Federal Legislation to Prohibit Discrimination Against 340B Safety Net Providers by Payers

Read more
pexels sora shimazaki 5668473

United Therapeutics Is Latest Manufacturer to File Lawsuit Against HHS On Contract Pharmacy Program

Read more
61287122 legislation word cloud concept

McKinley, Spanberger Introduce Bipartisan Legislation

Read more
RWC 340B Logo hi res

Ryan White Clinics Endorse McKinley-Spanberger Legislation to Prohibit Discrimination Against 340B Safety Net Providers, Protect Program Integrity

Read more
united states supreme court 6330563 1920 1

Supreme Court to Review Three Cases With Implications for 340B Covered Entities

Read more
pina messina kfJkpeI6Lgc unsplash

Boehringer Ingelheim Latest Manufacturer to Announce It Will No Longer Offer 340B Discounts at Most Contract Pharmacies

Read more
9 board of directors

Secretary of HHS Names ADR Board Members

Read more
9 board of directors

HHS Appoints 340B ADR Board Members

Read more

House Rep. McKinley Applauds HHS Letters to Manufacturers Condemning Refusal to Honor Contract Pharmacy Arrangements

Read more
pexels sora shimazaki 5668882

Filings in Drug Manufacturer Lawsuits Following HHS’s May 17 Letter

Read more
pexels pixabay 48195

HRSA Informs Six Manufacturers That Their Contract Pharmacy Policies Violate the 340B Statute

Read more

Gilead’s HIV Drug Reimbursement Cut Will be Devastating, 340B Covered Entities Say

Read more

NY State 340B Providers Get More Time to Challenge Reimbursement Change

Read more

226 Members of Congress Call on HHS Secretary to Protect 340B Program

Read more

At-Risk Communities Need a Covid Hero to Protect Critical Federal Resources

Read more

‘Nightmare scenario’: State cuts could impact HIV/AIDS patients across region

Read more

Novo Nordisk and United Therapeutics Are the Latest Drug Manufacturers to Limit Access to 340B Prices at Contract Pharmacies

Read more

Press Release: RWC-340B and 340B Covered Entity Plaintiffs Ask Secretary of HHS to Immediately Enforce Covered Entities’ Rights Under 340B Statute

Read more

217 Congressional Representatives Send Letter to Secretary Azar Opposing the Kalderos Rebate Model

Read more

Novartis Takes a Less Restrictive Approach to 340B Pricing at Contract Pharmacies

Read more

RWC-340B/CV340B National Advocacy Webinar

Read more

Sentry Stands with Ryan White Clinics as Study Highlights Importance of Funding and 340B Program in Managing HIV/AIDS Epidemic

Read more
340B

Cancer Care and the 340B Program: “People in underserved communities don’t want to be test subjects”

Read more

RWC-340B and 340B Grantee Plaintiffs File Lawsuit Against HHS/HRSA to Protect 340B Contract Pharmacy Program from Manufacturer Attacks

Read more

Discriminatory Reimbursement Practices by PBMs Represent a Threat to Public Health: A Perspective from Community Health

Read more

Op Ed: “Keep up the progress against HIV and AIDS”

Read more

Congressional Letters to Secretary Azar to Object to Manufacturer Actions

Read more

RWC-340B Submits Letter to HHS Regarding Drug Manufacturers Actions That Undermine the 340B Program & Letter to HRSA Regarding 340B Telehealth Policies

Read more

Eli Lilly Announces New Limited Distribution Plan

Read more

Recap of Second 340B ESP™ Basic User Training Webinar

Read more

RWC-340B Press Statement on Recent Actions Taken by Drug Manufacturers

Read more

Manufacturers to Provide “340B Rebates” Through New Kalderos Software Platform

Read more

Novartis To Collect Contract Pharmacy Claims Data Through 340B ESP, TPAs and Specialty Pharmacies Express Concern Over Data Submitted

Read more

Astra-Zeneca Announces It Will No Longer Offer 340B Discounts at Most Contract Pharmacies

Read more

Reps. Matsui and Stewart Introduce Legislation to Protect 340B Hospitals During COVID-19 Pandemic

Read more

Court Upholds Medicare Part B Reimbursement Cuts for 340B Drugs

Read more

President Trump Signs Executive Orders on Lowering Drug Prices – Potential Impact for 340B Safety-Net Providers

Read more

Sanofi Announces 340BESP Participation and Consequences

Read more

Press Release: White House Executive Orders Undermine 340B Program

Read more

Recent Actions by Drug Manufacturers Merck and Eli Lilly Pose a Threat to Safety-Net Provider’s Ability to Access Drugs at 340B Prices

Read more

USCHA Announces Virtual Conference and Free Registration

Read more

Discriminatory Reimbursement Bill Hits Roadblock in Tennessee Senate

Read more

Ryan White Clinics Want More Flexibility to Help Fight COVID-19

Read more

Sentry Data Systems joins Ryan White Clinics for 340B Access (RWC-340B) in the fight to protect the nation’s most vulnerable patients

Read more

Candy Samples’ Powers for Good Shannon Stephenson/Cempa Community Care

Read more

Defense in Congress, Offense in the States: Ryan White Clinics Fighting Against Discriminatory 340B Reimbursement

Read more

COVID-19 Policies & Procedures

Read more

FDA Relaxes Blood Donation Requirements

Read more

Resources for the COVID-19 Crisis

Read more

CMS Releases Telehealth Toolkit to Guide Providers during COVID-19 Emergency

Read more

HRSA/OPA Guidance in Response to COVID-19 and DEA Waiver on Controlled Substance Prescriptions

Read more

340B and Telehealth/HHS Waivers

Read more

Shannon Stephenson Recognized in the Chattanoogan Publication

Read more

Presidential Budget Proposes 340B Savings Usage Records, Covered Entity User Fees, and Expanded HRSA Authority

Read more

HRSA Audit Results Reveal Manufacturer Overcharges

Read more

GAO Issues Report Criticizing HHS’ Oversight of 340B Duplicate Discounts

Read more

MedPAC Finds No Clear Link Between 340B Program and Increased Drug Spend

Read more

GAO Issues Report Criticizing HRSA Oversight of Nongovernmental Hospitals

Read more

HRSA Awards Prime Vendor Agreement to Apexus

Read more

CMS Issues Informational Bulletin on State Duplicate Discount Practices

Read more

DC Circuit Rules on 340B Medicare Advantage Discriminatory Reimbursement Case

Read more

Apexus Publishes Tool for Grantee Combined Purchasing and Distribution Requests

Read more

RWC-340B National Conference /// January 6-7, 2020

Read more

AIR340B Releases Updated Study on Charity Care Rates at 340B Hospitals

Read more

Rep. Mary Gay Scanlon Visits AIDS Care Group Clinic

Read more

New All-Agency Executive Orders May Undermine 340B Guidance

Read more

OPA Reevaluates 340B Program Policies

Read more

CMS To Survey Hospitals About Acquisition Costs for 340B Drugs

Read more

CVS-Sentry Settlement Pending in Antitrust Lawsuit

Read more

CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment Meeting – November 13 & 14

Read more

Cempa Community Care Awarded Champions of Health Care Award

Read more

HHS Secretary Alex Azar Visits Damien Center

Read more

HRSA Voids Audit Findings Against FQHC Following Lawsuit

Read more

HRSA to Collect Information Regarding Clients Receiving Non-Funded Outpatient Ambulatory Health Services

Read more

Senate Finance Committee Approves Major Drug Pricing Bill

Read more

Study Finds that Peer-to-Peer Connections Help Individuals with Unsuppressed HIV Get the Care Necessary to Achieve Viral-suppression

Read more

Court Issues Final Order in 340B Reimbursement Lawsuit – HHS Appeals

Read more

District Court Strikes Down Final Rule Requiring Manufacturers to Advertise List Prices

Read more

White House Withdraws Proposed Medicare & Medicaid Rebate Rule Change

Read more

Medicare Program Loses Out On Over $70 Million in Part D Rebates

Read more

RWC-340B Submits Comment Letter to HRSA Contesting Registration Policy for RWCs and STD Clinics

Read more

HRSA to Collect Information on Manufacturer Audit Process

Read more

HRSA Multisite Registration Policy for Non-FQHC Grantees

Read more

Senate HELP Committee Releases Draft Legislation to Reduce Health Care Costs

Read more

340B Annual Recertification For STD, TB and Title X Grantees In Process

Read more

May 9 House E&C Health Subcommittee hearing

Read more

Final Rule Will Require Drug Manufacturers to Disclose Prices in TV Advertisements

Read more

Court Holds 2019 Reimbursement Cuts for 340B Drugs Unlawful; Remands to HHS for Remedy for 2018 and 2019

Read more

340B Ceiling Price Website Update – HRSA to Publish Additional Pricing Data Elements

Read more

HRSA Adopts New RSR Requirements to Include Data on Services Funded by Program Income

Read more

340B Hospitals Provide More Care to Underserved Populations Than Non-340B Providers

Read more

Sentry Allowed to Continue Antitrust Lawsuit Against CVS and Wellpartner

Read more

HRSA Launches 340B Ceiling Price Website

Read more

RWC-340B Fly-in, April 16, 2019

Read more

Guidance on Purchase of Mobile Vans with Program Income

Read more

Trump Administration’s 2020 Budget Proposal – Significant Changes to 340B, Global HIV/AIDS Funding, and Medicare and Medicaid

Read more

CANN National 340B Commission Releases Report Calling for Harmful Changes to the 340B Program

Read more

HHS Files Status Report on Publishing of 340B Ceiling Prices

Read more

CDC Finds Rate of New HIV Infections has Stalled

Read more

Top Executives from Pharmaceutical Companies Testify Before Senate Finance Committee

Read more
Department of Health and Human Services

HHS Appeals Permanent Injunction Stopping 340B Reimbursement Cuts

Read more

HRSA Webinar on the 340B OPAIS Pricing Component – March 11, 2019

Read more

340B Annual Recertification in Full Swing

Read more

CVS Caremark Will Not Implement Planned 340B Payment Cuts

Read more

CVS Caremark to Delay Reimbursement Cuts Until April 1

Read more

Hospital Groups File Amended Complaint to Compel HRSA to Publish 340B Ceiling Prices

Read more

California Medicaid Will Transition All Pharmacy Services to Fee-for-Service

Read more

Ryan White HIV/AIDS Providers Achieve Record Levels of Viral Suppression in 2017

Read more

Court Rules in Hospitals’ Favor in 340B OPPS Cuts Lawsuit

Read more

2018 National Ryan White Conference

Read more

RWC-340B on the Hill

Read more

HRSA to Begin Publishing 340B Ceiling Prices in 2019

Read more

HHS Finalizes Manufacturer CMP and Penny Pricing Rule Effective January 1, 2019

Read more

HRSA Reporting on Services Funded Through Program Income

Read more

HAB Revises Policy on Allowable Uses of Ryan White Grant Funds

Read more

RWC-340B Leaders Meet with HRSA Administrator and Key HHS Staff

Read more

Proposed Rule Would Require Drug Manufacturers to Disclose Prices in TV Advertisements

Read more

New Legislation to Fight Opioid Epidemic Clears Congress, President Expected to Sign

Read more

Gilead Will Begin Marketing Lower Cost Hepatitis C Drugs in January

Read more
Department of Health and Human Services

Hospital Groups File Lawsuit Challenging CMP Rule Delay

Read more

Hospitals Refile Lawsuit Challenging 2018 OPPS Rule

Read more

E&C Chairmen Request Information from 340B Contract Pharmacies

Read more

Ask Your Representative to Support Ryan White Clinics by Co-Sponsoring H.R.6071, The SERV Act

Read more

Hospitals Lose Court Case Challenging Reimbursement Cuts to 340B Drugs

Read more

RWC-340B Comments on “HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs”

Read more

E&C Health Subcommittee Reviews 340B Program and Recent GAO Report on Contract Pharmacies

Read more

E&C Health Subcommittee to Hold 340B Hearing on July 11

Read more

RWC-340B Asks HHS for Flexibility to Use Program Income to Address the Opioid Crisis

Read more

House Appropriations Committee Proposes Increased Funding for OPA

Read more

OPA Describes Best Practices for Resolving Contract Pharmacy Non-Compliance

Read more

OMB Increases Thresholds for Grantee Micro-Purchases and Small Purchases

Read more

Senate HELP Drug Pricing Hearing, 340B Not Addressed

Read more

Senate HELP Committee to Hold Third 340B Hearing on June 19

Read more
Rep. Doris Matsui

Ryan White Clinics for 340B Access Supports Rep. Matsui’s SERV Act

Read more

RWC-340B to Celebrate 340B All Stars!

Read more

Senate HELP Announces Second 340B Hearing

Read more

HRSA Proposes 12-Month Delay of CMP Rule

Read more

HRSA Withdraws Proposal to Weaken CMP Rule

Read more

Two Bills Potentially Impacting the 340B Program

Read more

RWC-340B Sponsors Congressional Briefing on How and Why 340B Program Works for Minority Populations

Read more

Ensuring the Value of the 340B Program Act Threatens Continuum of Care for HIV/AIDS Patients & Future of the 340B Program

Read more
340B

PAUSE Act Threatens Continuum of Care for HIV/AIDS Patients & Future of the 340B Program

Read more
340B

HELP Act Threatens Continuum of Care for HIV/AIDS Patients & Future of the 340B Program

Read more

RWC-340B Sends Letter to Santa Clara County Board of Supervisors Member Regarding 340B Support

Read more

RWC-340B Responds to Rep. Scott Peters’ Open Letter to Grantees

Read more

HRSA Seeks Additional Delay of CMP Rule

Read more

Senate HELP Hearing “Perspectives on the 340B Drug Discount Program” Scheduled March 15

Read more

Sen. Grassley Introduces 340B Legislation

Read more

White House Council of Economic Advisors White Paper

Read more

President’s Budget Targets 340B / HHS Secretary Defends Budget Before Congress

Read more

Join RWC-340B to Discuss the State of the 340B Program and the Coalition’s Advocacy Efforts

Read more

Recertification is Just Around the Corner

Read more

New England Journal of Medicine Presents Distorted View of 340B Program

Read more

Hatch Suggests CMS Should Administer 340B Program

Read more

HRSA Revises Its Audit Policies

Read more

Legislation Mispresents Purpose of 340B Program, Threatens all Covered Entities

Read more

House E&C Committee Issues Report on 340B Program

Read more

340B Legislation Introduced

Read more

Update on 340B Ceiling Price and Manufacturer Civil Monetary Penalties

Read more

Ryan White Clinics in 340B Program Call for Constructive Dialogue

Read more

NIH Director Says March-In Rights Cannot Be Used to Lower Drug Prices

Read more

CMS Finalizes Part B Cuts for 340B Drugs

Read more

Opioid Epidemic Declared Public Health Emergency – Implications for Ryan White Grantees

Read more

House E&C Oversight Subcommittee Hearing on 340B

Read more

Bipartisan Letter from Senators Opposing Part B Cuts

Read more

340B Ceiling Price and Manufacturer CMP Rule

Read more

Upcoming House and Senate Hearings

Read more

Tom Price Resigns as HHS Secretary

Read more

Congressional Letter Opposing Part B Cuts

Read more

RWC-340B Signs on to 340B Coalition’s Comments Opposing CMP Final Rule

Read more

New OPA Database Is Open

Read more
Department of Health and Human Services

OIG Report on Track-and-Trace Law and 340B

Read more

AIR340B Issues Statement Applauding E&C Probe

Read more

E&C Committee Sends Letters to Covered Entities

Read more

Mylan to Refund Covered Entities for EpiPen Overcharges

Read more

340B Database Will Be Temporarily Unavailable

Read more

Recent GAO Report on 340B Program Oversight

Read more

AIR340B Senate Briefing Documents

Read more

RWC-340B at Annual 340B Conference

Read more

CMS Proposes Lower Reimbursement for Medicare Part B 340B Drugs

Read more

Ryan White Clinics for 340B Access’ Letter to the Energy and Commerce Committee

Read more

Draft Executive Order on Drug Prices

Read more

HRSA Pledges to Work With Congress on 340B Legislation

Read more

Health Care Reform Legislation Next Steps Memo

Read more

Senate HELP to Hold Hearing on Drug Spending

Read more

Collins and Cassidy Announce Plans for 340B Legislation at Air 340B Summit

Read more

House and Senate Appropriations Committees Bill

Read more

New HRSA Administrator

Read more
Department of Health and Human Services

Trump to Nominate 340B Critic to HHS Position

Read more

Johnson & Johnson to Issue 340B Overcharge Refunds

Read more

What to Expect Next in Health Care Policy

Read more

President Trump’s 2018 Budget

Read more

HRSA Delays 340B Ceiling Price/Manufacturer CMP Rule to May 22, 2017

Read more

AIR-340B Allies Ask Congress to Change the 340B Program

Read more

ACA Repeal and Replace

Read more

GAO Reviewing 340B Contract Pharmacy Arrangements

Read more

Manufacturers Increase WAC Prices for HIV Medications

Read more

Cuomo Proposes Medicaid Price Ceiling for High Cost Drugs

Read more

Humana/Aetna Deal Off

Read more

BREAKING NEWS – Mega-Guidance Withdrawn

Read more

Court Blocks Aetna Purchase of Humana

Read more

HRSA Publishes Final Rule Addressing 340B Ceiling Price Calculations and Manufacturer Penalties for Overcharging

Read more

HHS and White House Host Listening Session on Pre-Exposure Prophylaxis (PrEP)

Read more

Johns Hopkins Touts Ongoing Need for and Importance of Ryan White HIV/AIDS Program

Read more

CMS Releases Covered Outpatient Drug Rule; Clarifies 340B in Managed Care

Read more

RWC-340B Invited as Delegate to National Leadership Summit on 340B

Read more

RWC-340B Submits Comments on 340B Program Mega-Guidance

Read more

HRSA Releases Long-Awaited 340B Mega-Guidance, Elements Threaten RWCs

Read more

Celebrating 25 Years of the Ryan White Program

Read more

RWC-340B Comments on HRSA’s Proposed Regulations to Implement Civil Monetary Penalties on Drug Manufacturers That Overcharge

Read more

White House Releases Updated National HIV/AIDS Strategy

Read more

RWC-340B Launches Subscriber Option

Read more
Load more

Find us on:

Facebook page opens in new windowTwitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
CONTACT US
  • Contact Us
  • News
QUICK LINKS
  • Expert Advice
  • Advocacy
  • Benefactors
  • Members
                                                                            © 2021 Ryan White Clinics for 340B Access. RWC-340B is a 501(c)(4) non-profit corporation.
Go to Top
Translate »
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset